account_balance
Investment manager · 13F filer · SEC CIK 2011932
Exome Asset Management LLC
Reported value$162Mas of Jun 30, 2026
Positions52 15 new, 8 sold out
Top 10 weight44.6%GH alone is 6%
FiledAug 1445 days after quarter end
Portfolio · as of Jun 30, 2026
Where the money is
New or addedTrimmedHeld
GHGuardant Health Inc
6.2%Trimmed −18%
PRAXPraxis Precision Medicines I
5.6%Trimmed −40%
TGTXTg Therapeutics Inc
5.6%New
COGTCogent Biosciences Inc
5.0%Trimmed −24%
IONSIonis Pharmaceuticals Inc
4.3%Trimmed −20%
LLYEli Lilly & Co
4.1%Trimmed −22%
ABVXAbivax SA
3.9%New
ALMSAlumis Inc
3.5%Trimmed −27%
CYTKCytokinetics Inc
3.2%Trimmed −42%
ELVNEnliven Therapeutics Inc
3.1%Trimmed −54%
VERAVera Therapeutics Inc
2.6%Trimmed −15%
UNHUnitedhealth Group Inc
2.5%Trimmed −25%
GH6.2%PRAX5.6%TGTX5.6%
COGTCogent Biosciences Inc
5.0%Trimmed −24%
IONSIonis Pharmaceuticals Inc
4.3%Trimmed −20%
LLYEli Lilly & Co
4.1%Trimmed −22%
ABVX3.9%ALMS3.5%CYTK3.2%ELVN3.1%VERA2.6%UNH2.5%Boxes show the top 12 stocks, sized against each other. The bar above shows how much of the fund they are. 13F only covers US-listed stocks, so foreign holdings and short positions are missing.
Show the top 12 as a list
GH Guardant Health Inc 6.2% Trimmed −18%PRAX Praxis Precision Medicines I 5.6% Trimmed −40%TGTX Tg Therapeutics Inc 5.6% NewCOGT Cogent Biosciences Inc 5.0% Trimmed −24%IONS Ionis Pharmaceuticals Inc 4.3% Trimmed −20%LLY Eli Lilly & Co 4.1% Trimmed −22%ABVX Abivax SA 3.9% NewALMS Alumis Inc 3.5% Trimmed −27%CYTK Cytokinetics Inc 3.2% Trimmed −42%ELVN Enliven Therapeutics Inc 3.1% Trimmed −54%VERA Vera Therapeutics Inc 2.6% Trimmed −15%UNH Unitedhealth Group Inc 2.5% Trimmed −25%
What changed